Sales decline 67.43% to Rs 2.13 crore
Net loss of Parmax Pharma reported to Rs 0.70 crore in the quarter ended September 2022 as against net profit of Rs 1.14 crore during the previous quarter ended September 2021. Sales declined 67.43% to Rs 2.13 crore in the quarter ended September 2022 as against Rs 6.54 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales2.136.54 -67 OPM %-5.6325.99 -PBDT-0.231.62 PL PBT-0.701.14 PL NP-0.701.14 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content